Palantir Market Analysis 2026 – PLTR +30%

Palantir Market Analysis

Palantir Surges Up to 30% as Guidance Gets Its Largest-Ever Raise — The Growth-vs-Valuation Debate Just Tilted Hard Toward Growth

Key Questions

Our July 27 update said August 3 needed to exceed already-elevated guidance, not just confirm it — did it

Worth going straight to the specific numbers we flagged as the bar to clear. Management’s own Q2 guidance called for revenue of $1.797–1.801 billion. Here’s what actually landed: Palantir reported Q2 2026 revenue of $1.94 billion, up 93% year-over-year — its highest growth rate ever — beating that guidance by roughly $140 million and beating Street consensus of about $1.8–1.81 billion. The number that matters most for the “is this deceleration or acceleration” question we posed: US commercial revenue grew 149% year-over-year to $764 million, accelerating from Q1’s already-exceptional 133% rather than slowing toward it. US government revenue grew 90% to $809 million, and total US revenue reached $1.573 billion, now representing more than 81% of total revenue. Adjusted EPS came in at $0.41 against a $0.34–0.35 consensus. The company’s Rule of 40 score, which stood at 145% last quarter, climbed further to 155%. What this means in practice: the market’s July anxiety was about whether Palantir could keep exceeding an already-elevated bar — it did, and by a wider margin than the prior quarter, not a narrower one.

This week at a glance:

• PLTR price: ↑↑↑ from $122–125 (July 24–25) to $125.96 (Monday close) to as much as $163–164 intraday Tuesday, a single-session surge of up to 30%
• Rule of 40 score: ↑ climbed to 155%, up from Q1’s 145%
• US commercial revenue growth: ↑↑ accelerated to 149% YoY, from Q1’s 133%
• FY2026 revenue guidance: ↑↑ raised to $8.15–8.158 billion (82% growth), from $7.65–7.66 billion — the company’s largest-ever single-quarter guidance raise
• FY2026 US commercial guidance: ↑↑ raised to above $3.424 billion (134%+ growth), from above $3.224 billion
• Analyst targets: ↑↑ Citi to $245, UBS to $220, Mizuho to $215, Goldman Sachs to $204; Deutsche Bank upgraded to Buy from Hold; Jefferies the outlier at $80
• Market cap: ↑↑ climbed from ~$294.7 billion toward the ~$400 billion level some analysts had floated as a bull-case scenario for the next year — reached within days rather than a year

With targets now ranging from $80 to $245, is the valuation debate actually more resolved or less resolved than before earnings

Worth being honest that this is less resolved than the growth numbers alone would suggest. In the hours after the report, Citi’s Tyler Radke raised his target to $245 from $200, citing accelerating revenue growth, record commercial bookings, and stronger contract metrics; UBS moved to $220, Mizuho to $215, Goldman Sachs to $204, Northland to $200, and D.A. Davidson’s Gil Luria to $200 from $175, citing Palantir’s ability to switch between AI models with minimal disruption as a durable advantage. Deutsche Bank upgraded the stock outright to Buy from Hold, calling the quarter exceptional. Worth naming the holdout directly: Jefferies raised its target only to $80 from $70 — still roughly half of Monday’s pre-earnings closing price and less than a third of where the stock traded Tuesday — a reminder that even a blowout quarter didn’t convince every desk that the current multiple (above 40 times forward sales by some estimates) is sustainable. What this means in practice: the operating business question our July 27 update posed is now answered; the valuation question — what valuation the business can justify — remains genuinely, and now more visibly, contested.

Key Facts

Current Price & Valuation

• Current price: surged as much as 30% intraday Tuesday, August 4, trading in the $163–164 area after a $125.96 close Monday, August 3
• Premarket reaction: +15.4% to $145.05 at 4:17am ET; shares broke above $150 during the regular session, then extended gains through midday
• 52-week range: $106.37–$207.52; Tuesday’s move puts shares roughly 21–22% below the 52-week high, versus roughly 41% below it before the report
• Market cap: climbed from approximately $294.7 billion toward roughly $390 billion, approaching the $400 billion level some analysts had floated as a bull-case scenario for the next 12 months
• Post-earnings analyst target range: $80–$245 (Jefferies at the low end; Citi at the high end) — an unusually wide spread even for Palantir

Q2 2026 Results (reported August 3, 2026, after market close)

• Revenue: $1.94 billion (+93% YoY, +19% sequentially), beat management’s own $1.797–1.801B guidance and ~$1.8–1.81B consensus
• US revenue: $1.573 billion (+115% YoY, +23% sequentially), now more than 81% of total revenue
• US commercial revenue: $764 million (+149% YoY) — accelerated from Q1’s 133% growth
• US government revenue: $809 million (+90% YoY, +18% sequentially)
• GAAP operating income: $912 million (47% margin); adjusted operating income: $1.19 billion (62% margin), beat guidance of $1.063–1.067B
• GAAP net income: $1.06 billion; GAAP and adjusted EPS: $0.41 (vs. $0.34–0.35 consensus), up from $0.13 a year earlier
• Adjusted free cash flow: $1.22 billion for the quarter
• Rule of 40 score: 155%, up from 145% in Q1
• Total contract value (TCV): $3.37 billion (+49% YoY); US commercial TCV bookings: $2.132 billion (+153% YoY, record); US commercial remaining deal value: $6.24 billion, more than double a year ago
• Closed a record 220 deals ≥$1 million, including 98 deals ≥$5 million and 70 deals ≥$10 million

Updated Guidance

• FY2026 revenue: raised to $8.15–8.158 billion (82% YoY growth), up from $7.65–7.66 billion — the company’s largest-ever single-quarter guidance raise, an 11-percentage-point increase in the implied growth rate
• FY2026 US commercial revenue: raised to above $3.424 billion (134%+ growth), up from above $3.224 billion
• FY2026 adjusted income from operations: raised to $4.889–4.897 billion, up from $4.440–4.452 billion
• FY2026 adjusted free cash flow: raised to $4.5–4.7 billion, up from $4.2–4.4 billion
• Q3 2026 guidance: revenue $2.16–2.164 billion; adjusted income from operations $1.292–1.296 billion

Analyst Reactions

• Citi (Tyler Radke): raised target to $245 from $200, Buy
• UBS: raised target to $220 from $200
• Mizuho: raised target to $215 from $185
• Goldman Sachs: raised target to $204 from $183
• Northland: raised target to $200 from $190
• D.A. Davidson (Gil Luria): raised target to $200 from $175, Buy
• Deutsche Bank: upgraded to Buy from Hold
• Jefferies: raised target only to $80 from $70 — the clear cautious outlier, still well below the pre-earnings closing price

Unchanged / Still Open From Prior Update

• Michael Burry’s disclosed short positioning toward Palantir — no confirmed update on the position as of this report
• Open-source competitive product discussion and Palantir’s CTO’s comments on Chinese AI models — no material new developments since our last update
• Approximately 4,430 employees company-wide; revenue-per-employee framing continues to rise given this quarter’s growth

Palantir’s setup the day after earnings is close to a best-case resolution of the specific tension we’d been tracking: exceptional execution not merely continuing but accelerating on the metric (US commercial growth) most in question, paired with the company’s largest-ever guidance raise. What remains open — and, based on the $80-to-$245 analyst spread, more visibly open than before — is whether a stock now approaching a $390 billion market cap and 40x-plus forward sales can keep growing into that valuation, or whether Tuesday’s surge itself becomes the new, higher bar the next report has to clear.

The live chart below reflects current PLTR share price action in real time.

A Blowout Quarter Answered the Growth Question — It Didn’t Answer the Valuation Question

The instinctive read on a stock surging up to 30% in a single session is that the market has resolved its prior uncertainty. The data says something more specific: the operating uncertainty is resolved — US commercial growth accelerated rather than decelerated, and guidance rose by the largest margin in company history. The valuation uncertainty is not resolved; if anything, the $80-to-$245 spread in same-day analyst targets is wider than the range implied by pre-earnings sentiment, which had mostly clustered Wedbush’s more optimistic $230 against a more moderate consensus in the $180s–190s. So what does this mean in practice: Tuesday’s move reflects the market paying up for confirmed, accelerating growth, not the market reaching consensus on what Palantir is ultimately worth — those are different things, and the second one remains as contested after this report as before it.

Worth stating the contrarian framing directly: Jefferies’ decision to raise its target only modestly, to $80 from $70, even after a quarter every other major bank treated as a clear positive catalyst, is a genuine, dated signal that at least one desk views the current multiple as disconnected from any reasonable growth-adjusted valuation framework, regardless of how strong the underlying execution is. That view is a distinct minority among the banks that updated targets this week, but it isn’t a fringe one — Jefferies has held a comparably cautious stance on Palantir’s valuation across prior quarters as well.

Valuation Context

Palantir is an integrated software platform rather than a clean sum-of-the-parts business, so its valuation is dominated by the interaction between exceptional growth and an exceptionally demanding sales multiple. The key question is how long US commercial and total revenue growth can remain high enough to support that premium as comparisons become harder.

Third-party post-earnings targets reviewed in this article range from roughly $80 to $245, one of the widest dispersions in the coverage set. MatrixPro24 uses that spread as evidence that the market has not reached a stable valuation consensus; it is not a MatrixPro24 fair-value range, expected-return forecast, or share-price target.

Current Market Data

Palantir trades on Nasdaq under ticker PLTR. Shares closed at $125.96 on Monday, August 3, then surged as much as 30% intraday Tuesday, August 4, trading in the $163–164 area following Q2 2026 earnings and the company’s largest-ever guidance raise. The stock sits within a 52-week range of $106.37–$207.52. Market capitalization has climbed toward approximately $390 billion. Q3 2026 earnings are expected in early November 2026. The live chart below reflects current price action.

Sources

• Business Wire — Palantir Reports Q2 2026 Results, Raises FY2026 Guidance
• Quartz — Palantir Q2 2026 Earnings: Revenue Up 93%, Guidance Raised
• Finbold — Wall Street Analysts Update Palantir Stock Price Target After Blowout Earnings
• 24/7 Wall St. — After Palantir’s Blowout Earnings, Here’s Where the Stock Could Head Next
• TradingKey — Palantir Earnings Beat, Guidance Raise Fuel Software Recovery
• Yahoo Finance — Palantir Technologies Inc. (PLTR) Stock Price, News, Quote & History
• Robinhood — Palantir Technologies (PLTR) Stock Price Quote & News

Palantir’s earnings landed the same week as Microsoft and Amazon, both of which also posted accelerating growth metrics that markets rewarded — a pattern this earnings season where confirmed, dated results are moving stocks more than guidance alone did in the weeks leading up to each report.

About MP24 Analyst X

Published by MP24 Analyst X. Read our Editorial and Content Policy to understand our compliance and brand publishing standards.

MP24 Analyst X is the public-facing pseudonym used for MatrixPro24’s research and editorial work across macroeconomics, commodities, cryptocurrencies, equities, and global financial markets. MatrixPro24 research emphasizes evidence, transparency, and structured reasoning over speculation and market hype.

Disclaimer

This analysis is for informational and educational purposes only and does not constitute personalized financial or investment advice or a MatrixPro24 recommendation to buy, sell, or hold a financial instrument. This editorial/compliance update was completed on August 12, 2026. Market-price figures and dated market reactions remain tied to the observation dates stated in the article; use the live TradingView chart for current market pricing. Past performance is not indicative of future results. Conduct your own independent research before making financial decisions.